SERB Pharmaceuticals

SERB is a global specialty pharmaceutical company with a growing portfolio of emergency and rare disease medications. For over 30 years, we have made it possible to treat these complex and life-threatening conditions, supporting clinicians, healthcare systems, and governments while bringing hope to patients and their families. SERB boasts the world’s most extensive range of antidotes, including medical countermeasures for chemical, biological, radiological, and nuclear (CBRN) threats. As a fully integrated company, SERB has the experience and capability to source, develop, and manufacture our medicines to the highest standards, delivering them worldwide through our secure supply chain. SERB operates in the United States as BTG Pharmaceuticals.